Filgrastim (R-Methug-Csf) in Clinical Practice - Couverture rigide

 
9780824700577: Filgrastim (R-Methug-Csf) in Clinical Practice
Couverture rigide
ISBN 10 : 0824700570 ISBN 13 : 9780824700577
Editeur : Marcel Dekker Inc, 1998

Synopsis

Providing a wealth of insights drawn from the experience of groundbreaking researchers working in the field, this Second Edition of a landmark volume brings preclinical and clinical studies of Filgrastim (r-metHuG-CSF) up to date with completely revised and expanded discussions of its biology, biochemistry, structure, pharmacology, clinical applications, and pharmacoeconomics.
Explores how Filgrastim reduces infectious complications in the management of cancer, AIDS, severe chronic neutropenia, neutropenia associated with nonmalignant autoimmune diseases, non-neutropenic infections, lymphoma, leukemia, diabetic foot infection, and more!
Now enhanced with 13 new chapters, Filgrastim (r-metHuG-CSF) in Clinical Practice, Second Edition features novel research as well as provocative and enhanced information on

  • pharmacokinetic-pharmacodynamic modeling to delineate concentration-response relationships
  • Filgrastim as treatment or prophylaxis for decreasing infectious episodes, intensifying immunosuppresive therapy, and mobilizing progenitor stem cells
  • improving granulocyte collection yields from normal donors and neutrophil transfusions in recipients of such products
  • the potential of peripheral blood progenitor cell (PBPC) transplantation in diseases, such as rheumatoid arthritis
  • maintaining optimal chemotherapy intensity in situations where dose reduction or delay is necessary
  • combining Filgrastim with various cytokines, including granulocyte-macrophage colony-stimulating factor, stem-cell factor, rHuSCF, IL-3, and erythropoietin
  • Filgrastim's toxicity profile, daily aspects of administration, economic impact, and effect on patients' quality of life
  • and much more!
    Containing over 1650 references-more than 600 new to this edition!-this truly outstanding Second Edition continues to furnish unparalleled coverage of the subject matter for oncologists, hematologists, infectious disease specialists, immunologists, radiotherapists, oncological nurses, and graduate and medical school students in these disciplines.

    • Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

    Présentation de l'éditeur

    Providing a wealth of insights drawn from the experience of groundbreaking researchers working in the field, this Second Edition of a landmark volume brings preclinical and clinical studies of Filgrastim (r-metHuG-CSF) up to date with completely revised and expanded discussions of its biology, biochemistry, structure, pharmacology, clinical applications, and pharmacoeconomics.
    Explores how Filgrastim reduces infectious complications in the management of cancer, AIDS, severe chronic neutropenia, neutropenia associated with nonmalignant autoimmune diseases, non-neutropenic infections, lymphoma, leukemia, diabetic foot infection, and more!
    Now enhanced with 13 new chapters, Filgrastim (r-metHuG-CSF) in Clinical Practice, Second Edition features novel research as well as provocative and enhanced information on

  • pharmacokinetic-pharmacodynamic modeling to delineate concentration-response relationships
  • Filgrastim as treatment or prophylaxis for decreasing infectious episodes, intensifying immunosuppresive therapy, and mobilizing progenitor stem cells
  • improving granulocyte collection yields from normal donors and neutrophil transfusions in recipients of such products
  • the potential of peripheral blood progenitor cell (PBPC) transplantation in diseases, such as rheumatoid arthritis
  • maintaining optimal chemotherapy intensity in situations where dose reduction or delay is necessary
  • combining Filgrastim with various cytokines, including granulocyte-macrophage colony-stimulating factor, stem-cell factor, rHuSCF, IL-3, and erythropoietin
  • Filgrastim's toxicity profile, daily aspects of administration, economic impact, and effect on patients' quality of life
  • and much more!
    Containing over 1650 references-more than 600 new to this edition!-this truly outstanding Second Edition continues to furnish unparalleled coverage of the subject matter for oncologists, hematologists, infectious disease specialists, immunologists, radiotherapists, oncological nurses, and graduate and medical school students in these disciplines.

    • Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

    Éditeur
    Marcel Dekker Inc
    Date d'édition
    1998
    Langue
    anglais
    ISBN 10 
    0824700570
    ISBN 13 
    9780824700577
    Reliure
    Relié
    Numéro d'édition
    2
    Nombre de pages
    673
    Éditeur
    Morstyn George, Dexter T. Michael, Foote Maryann
    Coordonnées du fabricant
    non disponible
    Personne responsable
    non disponible